Skip to main content

Barclays PLC

SEC CIK
0000312069
Latest filing
Aug 14, 2026

AMAM holding history

Ambrx Biopharma, Inc. in every 13F filed by Barclays PLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AMAM overviewAll 13F holders of AMAMFull Q2 2026 holdings

Shares (Q1 2024)
0
Sold out in Q1 2024
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q4 2023
Holdings of AMAM by Barclays PLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20240$00.0%−199,950−100.0%Sold outHolders
Q4 2023199,950$2.85M<0.1%+199,950NewHolders